Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Boundless Bio, Inc. (BOLD) had Non-Operating Income/Expense of $5.36M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-58.20M |
|
-- |
|
-- |
|
$63.55M |
|
$-63.55M |
|
|
Non-Operating Income/Expense |
$5.36M |
$-58.20M |
|
$-58.20M |
|
$-58.20M |
|
$-58.20M |
|
$-58.20M |
|
$-58.20M |
|
$-63.55M |
|
$-62.30M |
|
22.36M |
|
22.36M |
|
$-2.60 |
|
$-2.60 |
|
| Balance Sheet Financials | |
$109.61M |
|
$3.22M |
|
$47.45M |
|
$157.06M |
|
$12.54M |
|
$45.87M |
|
$45.87M |
|
$58.41M |
|
$98.65M |
|
$98.65M |
|
$98.65M |
|
22.41M |
|
| Cash Flow Statement Financials | |
$-46.66M |
|
$37.80M |
|
$0.14M |
|
$27.15M |
|
$18.43M |
|
$-8.72M |
|
$6.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.74 |
|
-- |
|
-- |
|
0.32 |
|
0.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-58.99% |
|
-58.99% |
|
-37.05% |
|
-40.27% |
|
$4.40 |
|
$-2.11 |
|
$-2.09 |
|